Mechanistically, circLIFR bound and synergized with MSH2 protein, which augmented the interaction between MutSα and ATM, to up-regulate p73 expression, ultimately contributing to attenuate bladder cancer growth and cellular tolerance to CDDP (Fig. 7). The gene discussed is MSH2; the disease is urinary bladder carcinoma.